Sukhatme Mayukh's Form 4 filing
Roivant Sciences Ltd. (ROIV) · filed Dec 31, 2025
- Accession no.
- 0001140361-25-047122
- Filed
- Dec 31, 2025
- Trade date
- Dec 29-31, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $28.9M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sukhatme MayukhCIK 0001750050 | Director, Officer (President & CIO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | Common Shares | MOption exerciseAcquired | +748,358 | $12.68 | +$9,489,179.44 | 19,584,905 | Direct | |
| Dec 29, 2025 | Common Shares | SSaleDisposed | −311,873 | $21.74 | −$6,780,119.02 | 19,273,032 | Direct | |
| Dec 29, 2025 | Common Shares | JOtherDisposed | −436,485 | $21.74 | −$9,489,183.9 | 18,836,547 | Direct | |
| Dec 31, 2025 | Common Shares | MOption exerciseAcquired | +2,449,877 | $12.68 | +$31,064,440.36 | 21,286,424 | Direct | |
| Dec 31, 2025 | Common Shares | SSaleDisposed | −1,018,995 | $21.71 | −$22,122,381.45 | 20,267,429 | Direct | |
| Dec 31, 2025 | Common Shares | JOtherDisposed | −1,430,882 | $21.71 | −$31,064,448.22 | 18,836,547 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | Common Shares | MOption exerciseDisposed | −748,358 | $0.00 | $0 | 555,840 | Direct | |
| Dec 31, 2025 | Common Shares | MOption exerciseDisposed | −2,449,877 | $0.00 | $0 | 95,718 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.